Medtronic, Inc. (MDT) PT Raised to $94 at Barclays
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall St ends higher as stocks reclaim some shine
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Snowflake soars 20% on earnings beat and raised guidance
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Crude Inventory Fell 4.5M Barrels Last Week - EIA
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- TScan cuts 75% of workforce, pivots to solid tumor cell therapy
Medtronic, Inc. (MDT) PT Raised to $99 at Jefferies; Q2 Eases Growth Concerns
November 22, 2017 7:45 AM ESTJefferies raised its price target on Medtronic, Inc. (NYSE: MDT) to $99.00 (from $96.00) while maintaining a Buy rating following Q2 results.
Analyst Raj Denhoy said the results eased concerns of a slowing growth trajectory.
"Despite weather impacts, F18 guidance for +4-5% sales and... More
Medtronic, Inc. (MDT) PT Raised to $86 at Wells Fargo on 2Q Report; 'Better gross Margin Than Modeled'
November 22, 2017 7:28 AM ESTWells Fargo raised its price target on Medtronic, Inc. (NYSE: MDT) to $86.00 (from $83.00) while maintaining a Market Perform rating, following the company's second quarter earnings report.
Analyst Larry Biegelsen notes a positive outlook on the shares, as the company reported second quarter... More
Medtronic, Inc. (MDT) PT Raised to $88 at Leerink Partners, Gorwth Should Accelerate in H2 2018
November 22, 2017 7:15 AM ESTLeerink Partners raised its price target on Medtronic, Inc. (NYSE: MDT) to $88.00 (from $85.00) while maintaining a Market Perform rating.
... MoreMedtronic, Inc. (MDT) PT Raised to $85 at Stifel
November 22, 2017 6:52 AM ESTStifel raised its price target on Medtronic, Inc. (NYSE: MDT) to $85.00 (from $83.00) while maintaining a Hold rating.
... MoreMedtronic, Inc. (MDT) PT Bumped to $95 at Needham & Company
November 21, 2017 3:46 PM ESTNeedham & Company analyst Mike Matson bumped his price target on Medtronic, Inc. (NYSE: MDT) to $95.00 (from $94.00) while maintaining a Buy rating following Q1 results that beat the Street and reiterated guidance.
Matson notes organic revenue growth improved to 4.0% (excluding Hurricane Maria)... More
Medtronic (MDT) Tops Q2 EPS by 8c, Reiterates Guidance
November 21, 2017 6:48 AM ESTMedtronic (NYSE: MDT) reported Q2 EPS of $1.07, $0.08 better than the analyst estimate of $0.99. Revenue for the quarter came in at $7.1 billion versus the consensus estimate of $6.93 billion.
Guidance
Medtronic today reiterated its revenue and non-GAAP EPS guidance. The company's guidance is given on a comparable, constant currency basis, which accounts for the divestiture of certain businesses from its prior period Patient Monitoring & Recovery division by removing the financial impact... More
